ACTIVE

Association Belge de Lutte contre la Mucoviscidose - Belgische Vereniging voor Strijd tegen Mucoviscidose

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result281,1 k €+145,8 %over 1 year
Revenue245,3 k €+6,4 %over 1 year
Equity3,8 M €+8,6 %over 1 year
Workforce17,5 ETP+1,7 %over 1 year

Identity

Source · BCE/KBO

Association Belge de Lutte contre la Mucoviscidose - Belgische Vereniging voor Strijd tegen Mucoviscidose is a Non-profit organization incorporated in 1966. Its main activity is: Activities of other membership organisations n.e.c.. Its registered office is in Auderghem. It employs on average 17,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0408.938.142
Incorporation
14/07/1966
Legal form
Non-profit organization
Registered office
Rue des Trois Ponts 124
1160 Auderghem · BruxellesSee on map
Latest accounts
31/12/2025
Average workforce
17,5 ETP
Joint committees (1)
  • 337
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowHealthy social debts

Financials

Source · NBB, 38 filings

Trend over 17 financial years

20252024202320222021
Income statement
Revenue245,3 k €230,6 k €285,9 k €355,8 k €430,9 k €
EBITDA-259,9 k €-630,1 k €-332,2 k €383,7 k €575,6 k €
Operating result-326,8 k €-698,2 k €-393,3 k €342,2 k €532,8 k €
Net result281,1 k €-613,9 k €-399,7 k €276,5 k €506,3 k €
Balance sheet
Equity3,8 M €3,5 M €4,1 M €4,5 M €4,2 M €
Total assets5,3 M €4,9 M €6,1 M €6,1 M €6,4 M €
Cash643,7 k €349,2 k €671,9 k €671,4 k €791,2 k €
Debts1,6 M €1,5 M €2 M €1,7 M €2,2 M €
Other
Workforce17,5 ETP17,2 ETP16,6 ETP14,9 ETP16,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

13 active · 38 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Ann Lemmens
Vice-chairman of the board of directors30/04/2022 → 17/05/2028
Catherine Struyf
Director17/05/2025 → 17/05/2028
David Klein
Director30/03/2019 → 17/05/2028Mandate2024 accountsended
Erik Aerts
Director30/03/2019 → 17/05/2028Secrétaire30/04/2022 → 2024 accountsendedMandate2022 accountsended
Isabelle De Cang
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Jonathan Monzée
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Marc De Backer
Director17/05/2025 → 17/05/2028
Mathias Levacq
Director17/05/2025 → 17/05/2028
Nele Vanleeuwe
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Pascal Borrey
Chairman of the board of directors30/04/2022 → 17/05/2028Mandate2022 accountsendedDirector2018 accountsendedManaging director2015 accountsended
Paul Maris
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Sophie Wustefeld
Director17/05/2025 → 17/05/2028
Tania Rombaut
Director17/05/2025 → 17/05/2028

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Marijke Proesmans
Director30/03/2019 → 2021 accounts
Philippe Schelpe
Director30/03/2019 → 2019 accounts
Pierre André Wustefeld
Director30/03/2019 → 2021 accounts
Rika De Schryver
Director30/03/2019 → 2021 accounts

Other companies at this address

Rue des Trois Ponts 124 1160 Auderghem
CompanyCBE no.
Cystic Fibrosis Europe● Active
1016.597.315

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/07/202627/05/202507/06/202416/05/202327/02/202326/04/2021
General meeting20/06/202617/05/202501/06/202422/04/202330/04/202227/03/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 38 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202520/06/202616/07/2026DutchPDF
Abridged model31/12/202520/06/202616/07/2026FrenchPDF
Abridged model31/12/202417/05/202527/05/2025FrenchPDF
Abridged model31/12/202417/05/202527/05/2025DutchPDF
Abridged model31/12/202301/06/202407/06/2024FrenchPDF
Abridged model31/12/202301/06/202407/06/2024DutchPDF
Abridged model31/12/202222/04/202316/05/2023DutchPDF
Abridged model31/12/202222/04/202316/05/2023FrenchPDF
Abridged model31/12/202130/04/202227/02/2023DutchPDF
Abridged model31/12/202130/04/202227/02/2023FrenchPDF
Abridged model31/12/202027/03/202126/04/2021DutchPDF
Abridged model31/12/202027/03/202125/04/2021FrenchPDF
Abridged model31/12/201905/09/202022/10/2020DutchPDF
Abridged model31/12/201905/09/202022/10/2020FrenchPDF
Abridged model31/12/201830/03/201918/04/2019DutchPDF
Abridged model31/12/201830/03/201918/04/2019FrenchPDF
Abridged model31/12/201717/03/201813/04/2018DutchPDF
Abridged model31/12/201717/03/201813/04/2018FrenchPDF
Abridged model31/12/201625/03/201725/04/2017FrenchPDF
Abridged model31/12/201625/03/201725/04/2017DutchPDF
Abridged model31/12/201519/03/201619/04/2016DutchPDF
Abridged model31/12/201519/03/201619/04/2016FrenchPDF
Abridged model30/06/201517/10/201513/11/2015FrenchPDF
Abridged model30/06/201517/10/201513/11/2015DutchPDF
Abridged model30/06/201415/11/201409/12/2014DutchPDF
Abridged model30/06/201415/11/201409/12/2014FrenchPDF
Abridged model30/06/201305/10/201305/11/2013DutchPDF
Abridged model30/06/201305/10/201305/11/2013FrenchPDF
Abridged model30/06/201210/11/201210/12/2012DutchPDF
Abridged model30/06/201210/11/201210/12/2012FrenchPDF
Abridged model30/06/201108/10/201107/11/2011DutchPDF
Abridged model30/06/201108/10/201107/11/2011FrenchPDF
Abridged model30/06/200924/10/200913/11/2009FrenchPDF
Abridged model30/06/200924/10/200913/11/2009DutchPDF
Abridged model30/06/200827/09/200830/09/2008DutchPDF
Abridged model30/06/200827/09/200830/09/2008FrenchPDF
Abridged model30/06/200720/10/200719/11/2007DutchPDF
Abridged model30/06/200720/10/200719/11/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

13 active · 38 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Ann Lemmens
Vice-chairman of the board of directors30/04/2022 → 17/05/2028
Catherine Struyf
Director17/05/2025 → 17/05/2028
David Klein
Director30/03/2019 → 17/05/2028Mandate2024 accountsended
Erik Aerts
Director30/03/2019 → 17/05/2028Secrétaire30/04/2022 → 2024 accountsendedMandate2022 accountsended
Isabelle De Cang
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Jonathan Monzée
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Marc De Backer
Director17/05/2025 → 17/05/2028
Mathias Levacq
Director17/05/2025 → 17/05/2028
Nele Vanleeuwe
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Pascal Borrey
Chairman of the board of directors30/04/2022 → 17/05/2028Mandate2022 accountsendedDirector2018 accountsendedManaging director2015 accountsended
Paul Maris
Director17/05/2025 → 17/05/2028Mandate2024 accountsended
Sophie Wustefeld
Director17/05/2025 → 17/05/2028
Tania Rombaut
Director17/05/2025 → 17/05/2028

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Marijke Proesmans
Director30/03/2019 → 2021 accounts
Philippe Schelpe
Director30/03/2019 → 2019 accounts
Pierre André Wustefeld
Director30/03/2019 → 2021 accounts
Rika De Schryver
Director30/03/2019 → 2021 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates19/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates27/12/2023
    ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates27/12/2023
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates27/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/03/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates15/12/2021
    ONTSLAGEN - BENOEMINGEN - DIVERSEN
    PDF
  • Mandates15/12/2021
    DEMISSIONS, NOMINATIONS - DIVERS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings17 filings
Mandates
Marc De Backer
Sophie Wustefeld
Mathias Levacq
Ann Lemmens
Erik Aerts
Tania Rombaut
Catherine Struyf
David Klein
Isabelle De Cang
Paul Maris
Nele Vanleeuwe
Jonathan Monzée
and 5 more mandates
196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
Association Belge de Lutte contre la Mucoviscidose - Belgische Vereniging voor Strijd tegen Mucoviscidose
Rue des Trois Ponts 124, 1160 Auderghem
Director
Director
Director
Vice-chairman of the board of directors
DirectorSecrétaire
Director
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Rue des Trois Ponts 124, 1160 AuderghemCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00305714

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Association Belge de Lutte contre la Mucoviscidose - Belgische Vereniging voor Strijd tegen MucoviscidoseCurrent
accounts 2008 → 2025
Accounts 2025 · 2026-00305714

Events

  1. 2025
    Annual accounts 2025281,1 k €↑
  2. 2024
    Annual accounts 2024-613,9 k €↓
  3. 2023
    Annual accounts 2023-399,7 k €↓
  4. 2022
    Annual accounts 2022276,5 k €↓
  5. 2021
    Annual accounts 2021506,3 k €↑
  6. 2020
    Annual accounts 2020-512 k €↓
  7. 2019
    Annual accounts 2019614,8 k €↑
  8. 2018
    Annual accounts 201840,7 k €↑
  9. 2017
    Annual accounts 2017-38,7 k €↑
  10. 2016
    Annual accounts 2016-1,1 M €↓
  11. 2015
    Annual accounts 201595,3 k €↑
  12. 2015
    Annual accounts 2015-35,1 k €↑
  13. 2014
    Annual accounts 2014-289,5 k €↓
  14. 2013
    Annual accounts 2013325,9 k €↑
  15. 2012
    Annual accounts 2012-2,5 k €↑
  16. 2009
    Annual accounts 2009-73,9 k €↓
  17. 2008
    Annual accounts 20089,6 k €
  18. 14/07/1966
    IncorporationNon-profit organization